Neoleukin Therapeutics, Inc.

NLTX · NASDAQ
Analyze with AI
12/31/2024
12/31/2022
12/31/2021
12/31/2020
Assets
Cash & Equivalents$136,586$37,887$142,467$192,556
Short-Term Investments$175,819$58,497$0$0
Receivables$0$0$0$0
Inventory$0$0$0$0
Other Curr. Assets$3,518$2,750$1,522$1,966
Total Curr. Assets$315,923$99,134$143,989$194,522
Property Plant & Equip (Net)$18,493$15,878$17,218$13,724
Goodwill$0$0$0$0
Intangibles$0$0$128$347
Long-Term Investments$0$0$0$0
Tax Assets$0$0$0$0
Other NC Assets$1,314$936$1,928$1,926
Total NC Assets$19,807$16,814$19,274$15,997
Other Assets$0$0$0$0
Total Assets$335,730$115,948$163,263$210,519
Liabilities
Payables$1,336$478$526$1,323
Short-Term Debt$2,999$1,515$1,221$708
Tax Payable$0$0$0$0
Deferred Revenue$0$0$0$0
Other Curr. Liab.$10,822$9,069$6,889$5,858
Total Curr. Liab.$15,157$11,062$8,636$7,889
LT Debt$9,429$10,555$11,763$11,414
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$769$0$0$0
Total NC Liab.$10,198$10,555$11,763$11,414
Other Liabilities$0$0$0$0
Cap. Leases$0$0$0$0
Total Liabilities$25,355$21,617$20,399$19,303
Equity
Pref Stock$0$0$0$0
Common Stock$0$0$0$0
Retained Earnings-$262,298-$451,055-$393,498-$332,806
AOCI$0-$21$0$0
Other Equity$572,673$545,407$536,362$524,022
Total Equity$310,375$94,331$142,864$191,216
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$335,730$115,948$163,263$210,519
Net Debt-$124,158-$25,817-$129,483-$180,434